BALYASNY ASSET MANAGEMENT L.P. - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 369 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$3,083,847
-80.8%
58,897
-85.1%
0.01%
-82.1%
Q1 2024$16,085,686
+351.3%
395,420
+310.0%
0.03%
+300.0%
Q4 2023$3,564,238
-56.4%
96,435
-54.9%
0.01%
-58.8%
Q3 2023$8,173,693
-15.7%
213,971
-20.4%
0.02%
-19.0%
Q2 2023$9,696,734
-8.0%
268,831
-2.6%
0.02%
-19.2%
Q1 2023$10,545,366
+201.2%
276,129
+348.7%
0.03%
+160.0%
Q4 2022$3,501,455
-25.8%
61,537
-48.5%
0.01%
-28.6%
Q3 2022$4,721,000
+1562.3%
119,406
+1588.9%
0.01%
+1300.0%
Q4 2021$284,000
-95.5%
7,070
-95.5%
0.00%
-96.3%
Q3 2021$6,368,000
-47.0%
156,530
-40.9%
0.03%
-52.6%
Q2 2021$12,026,000
+790.2%
264,828
+736.9%
0.06%
+612.5%
Q4 2020$1,351,000
+72.3%
31,643
-20.9%
0.01%
+166.7%
Q1 2018$784,000
+512.5%
40,005
+196.3%
0.00%
+200.0%
Q1 2016$128,000
-98.3%
13,500
-98.2%
0.00%
-98.5%
Q4 2014$7,321,000758,6450.07%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Third Security, LLC 14,092,771$206,177,00028.12%
BB BIOTECH AG 8,322,860$121,763,0003.90%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 398,633$4,579,0002.84%
DOHENY ASSET MANAGEMENT /CA 227,193$3,324,0002.43%
SNYDER CAPITAL MANAGEMENT L P 2,833,759$41,458,0002.24%
First Light Asset Management, LLC 938,399$13,729,0002.19%
IRIDIAN ASSET MANAGEMENT LLC/CT 9,027,164$132,067,0001.77%
Taylor Wealth Management Partners 204,277$2,989,0001.72%
Sterling Global Strategies LLC 22,000$321,860,0001.63%
Granite Investment Partners, LLC 988,939$14,468,0001.06%
View complete list of HALOZYME THERAPEUTICS INC shareholders